Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin.
Benjamin D
BD
Ehst
Erin M
EM
Warshaw
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004890:Erythema / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D005148:Facial Dermatoses / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D016559:Tacrolimus / Q000009:adverse effects* / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D014920:Wine
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; C117268:pimecrolimus; D001241:Aspirin; D016559:Tacrolimus